Comparison of effects of angiotensin peptides in the regulation of clitoral cavernosum smooth muscle tone.
The isometric tension measurement and in vitro autoradiography were used in clitoral cavernosum smooth muscle (CSM). Angiotensin ANG III, ANG IV, ANG II and ANG I induced contractions in clitoral CSM strips. ANG III and ANG I- induced contraction was five times less active than ANG II, whereas ANG IV-induced contraction was 1181-fold less potent than ANG II. Contractile responses to ANG III, ANG IV, ANG II and ANG I were significantly inhibited by type 1 ANG II (AT 1) receptor antagonist Dup 753 but not by type 2 ANG II (AT2) receptor antagonist PD 123,319. Pre-treatment with Nomega-nitro-L-arginine methyl ester, nitric oxide (NO) synthase inhibitor accentuated force of contraction induced by ANG III, ANG IV and ANG II. Amastatin, an aminopeptidase inhibitor enhanced ANG III- and ANG IV-induced contractions. Specific binding sites for 125I-ANG II were found in the clitoral CSM. Specific binding of 125I-ANG II was displaced by unlabeled ANG peptides. This study suggests that the contractile responses to all four peptides of the ANG family are mediated via AT1 receptors but not AT2 receptors. Further, the rank order of potency of contraction was as follows, ANG II> ANG I>ANG III>ANG IV. It is also suggested that peptides of the ANG family have a cross-talk with the NO system and aminopeptidase is involved in the modulation of the tone of clitoral CSM by ANG III and ANG IV.
Park
J K
JK
Department of Urology, Chonbuk National University Medical School, Keum-Am-Dong-San, Chonju, South Korea. rain@moak.chonbuk.ac.kr
Kim
S Z
SZ
Kim
J U
JU
Kim
Y G
YG
Kim
S M
SM
Cho
K W
KW
D000109:Acetylcholine / Q000494:pharmacology; D000626:Aminopeptidases / Q000037:antagonists & inhibitors / Q000378:metabolism; D057911:Angiotensin Receptor Antagonists; D000809:Angiotensins / Q000502:physiology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001345:Autoradiography; D018826:CD13 Antigens / Q000037:antagonists & inhibitors / Q000378:metabolism; D002987:Clitoris / Q000187:drug effects / Q000201:enzymology / Q000502:physiology*; D005260:Female; D043384:Glutamyl Aminopeptidase; D066298:In Vitro Techniques; D007537:Isometric Contraction; D009130:Muscle, Smooth / Q000187:drug effects / Q000201:enzymology / Q000502:physiology*; D009569:Nitric Oxide / Q000502:physiology; D010455:Peptides; D011480:Protease Inhibitors / Q000494:pharmacology; D011817:Rabbits; D011945:Receptors, Angiotensin / Q000502:physiology
D057911:Angiotensin Receptor Antagonists; D000809:Angiotensins; D000900:Anti-Bacterial Agents; D010455:Peptides; D011480:Protease Inhibitors; D011945:Receptors, Angiotensin; D009569:Nitric Oxide; C016977:amastatin; D000626:Aminopeptidases; D018826:CD13 Antigens; D043384:Glutamyl Aminopeptidase; D000109:Acetylcholine